1
Bortezomib and Thalidomide in Treating Patients With Newly Diagnosed Stage II or Stage III Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:March 1, 2018Completed
Stage III Multiple Myeloma: 437 Clinical Trials, Page 1 of 44
Hide Studies Not Open or Pending
2
Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:December 18, 2013Unknown status
3
Thalidomide, Doxorubicin, and Dexamethasone in Treating Patients With Untreated Stage II or Stage III Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:March 7, 2013Completed
4
Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:May 15, 2013Completed
5
High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:August 12, 2013Unknown status
6
S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma
Condition(s):Multiple Myeloma; Plasma Cell NeoplasmLast Updated:March 25, 2015Completed
7
Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:October 3, 2022Completed
8
Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:October 5, 2020Terminated
9
Doxorubicin Hydrochloride Liposome, Melphalan, and Bortezomib in Treating Patients With Relapsed or Refractory Stage I, Stage II, or Stage III Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:January 10, 2014Unknown status
10
Aflibercept for Relapsed Multiple Myeloma
Condition(s):Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:February 8, 2021Terminated